Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Anemia|Breast Cancer|Chronic Myeloproliferative Disorders|Drug/Agent Toxicity by Tissue/Organ|Leukemia|Lung Cancer|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Precancerous Condition|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: epoetin alfa|OTHER: placebo
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)